Guihai Liu
Overview
Explore the profile of Guihai Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
1004
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang Z, Damianou A, Vendrell I, Jenkins E, Lassen F, Washer S, et al.
Cell Rep
. 2024 Apr;
43(5):114152.
PMID: 38669140
Activation of the NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) inflammasome complex is an essential innate immune signaling mechanism. To reveal how human NLRP3 inflammasome assembly and activation are...
2.
Hamid M, Cespedes P, Jin C, Chen J, Gileadi U, Antoun E, et al.
Nat Immunol
. 2024 Apr;
25(5):834-846.
PMID: 38561495
Cancer remains one of the leading causes of mortality worldwide, leading to increased interest in utilizing immunotherapy strategies for better cancer treatments. In the past decade, CD103 T cells have...
3.
Chen X, Liu G, Wu B
Heliyon
. 2023 Nov;
9(11):e21164.
PMID: 37928041
This work intends to examine the diagnostic, prognostic, and biological roles of PSMD1 (proteasome 26S subunit, non-ATPase 1) in liver hepatocellular carcinoma (LIHC) and other malignancies, using bioinformatics techniques. PSMD1...
4.
Cui F, Wang Y, Liu G
Environ Sci Pollut Res Int
. 2023 Nov;
30(56):119385-119405.
PMID: 37924410
With the acceleration of urbanization and industrialization, the increasingly prominent contradiction between urban industrial development and urban land supply and demand highlights the need to explore the intricate interplay between...
5.
Wellington D, Yin Z, Yu Z, Heilig R, Davis S, Fischer R, et al.
Heliyon
. 2023 Oct;
9(10):e20076.
PMID: 37842619
Mutations within viral epitopes can result in escape from T cells, but the contribution of mutations in flanking regions of epitopes in SARS-CoV-2 has not been investigated. Focusing on two...
6.
Milighetti M, Peng Y, Tan C, Mark M, Nageswaran G, Byrne S, et al.
iScience
. 2023 Jun;
26(6):106937.
PMID: 37275518
T cell responses precede antibody and may provide early control of infection. We analyzed the clonal basis of this rapid response following SARS-COV-2 infection. We applied T cell receptor (TCR)...
7.
Yin Z, Chen J, Lu Y, Wang B, Godfrey L, Mentzer A, et al.
Cell Rep
. 2023 May;
42(5):112470.
PMID: 37141092
Most existing studies characterizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell responses are peptide based. This does not allow evaluation of whether tested peptides are processed and presented...
8.
Zang C, Zhao Y, Liu G, Li K, Qin L, Zhang Y, et al.
Front Immunol
. 2023 Jan;
13:982578.
PMID: 36618423
Background: Ablative therapy is a recommended treatment for hepatocellular carcinoma (HCC) not only for its effective eradication of tumors, but also for its induction of host immunity. However, the high...
9.
Peng Y, Felce S, Dong D, Penkava F, Mentzer A, Yao X, et al.
Nat Immunol
. 2021 Dec;
23(1):50-61.
PMID: 34853448
NP-B*07:02-specific CD8 T cell responses are considered among the most dominant in SARS-CoV-2-infected individuals. We found strong association of this response with mild disease. Analysis of NP-B*07:02-specific T cell clones...
10.
I de Silva T, Liu G, Lindsey B, Dong D, Moore S, Hsu N, et al.
iScience
. 2021 Nov;
24(11):103353.
PMID: 34729465
We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating global sequence data. Several variants within nucleocapsid and ORF3a epitopes have arisen independently in multiple lineages and...